Newsroom | 9208 results
Sorted by: Latest
-
AtriCure to Announce First Quarter 2026 Financial Results
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2026 financial results on Tuesday, May 5, 2026. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Tuesday, May 5, 2026, to discuss its first quarter financial results. Those interested in listening to th...
-
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
NEWTON, Mass.--(BUSINESS WIRE)--4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program...
-
ELRIG Announces Inaugural US Drug Discovery Conference
CAMBRIDGE, England--(BUSINESS WIRE)--ELRIG announces Drug Discovery USA 2026. The inaugural event takes place at Pfizer in Cambridge, MA from 16–17 June and is free to attend....
-
Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--DEEPER REVEAL clinical trial (NCT05358353) 12-month results evaluating the Spur Stent were presented at the SIR 2026 Annual Scientific Meeting....
-
WHOOP Selected for Inclusion in CMS’s ACCESS Program to Bring Technology-Enabled Care to Medicare Beneficiaries
BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced that its affiliated health care provider, WHOOP Physician Services, PC, was selected into the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s ACCESS program, a new initiative designed to expand access to high-quality, technology-enabled care for Medicare beneficiaries managing chronic conditions. Through this program, eligible Medicare beneficiaries will be able to receive WHOOP and its data-dr...
-
Protaryx Medical Receives FDA 510(k) Clearance for Its Breakthrough Transseptal Puncture Device
BALTIMORE--(BUSINESS WIRE)--Protaryx Medical Receives FDA 510(k) Clearance for Its Breakthrough Transseptal Puncture Device...
-
-
Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the Infusion Nurses Society (INS) 2026 Annual Meeting taking place in Louisville, KY from April 11 – 14, 2026. The event will bring together leading clinicians, researchers, healthcare professionals and industry leaders all dedicated to advancing vascular access and infusion therapy practice. Attendees will have the opport...
-
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health, to support cardiovascular disease awareness, prevention, and community health initiatives. “New data from the American Heart Association shows that cardiovascular disease continues to take an enormous toll on families and communities,” said Kristen Eisenhau...
-
EBR Systems to Participate at Heart Rhythm 2026
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only leadless left ventricular endocardial pacing (LVEP) system for heart failure, today announced its participation in the Heart Rhythm 2026 conference, taking place April 23-26, 2026, in Chicago, IL. EBR will have a strong presence at the conference, including an exhibit booth showcasing the WiSE® System and participation in multiple scientific sessions. The following talks are sponsored by EBR: Real World Experie...